Coronavirus: South Yorkshire | Department of Health and Social Care | Written Answers The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.
General Practitioners | Department of Health and Social Care | Written Answers The number of full-time equivalent (FTE) doctors working in general practice in England in each year since September 2015 is presented in th
General Practitioners: Training | Department of Health and Social Care | Written Answers The number of doctors accepting a place on general practitioner (GP) speciality training has been increasing year on year.
Coronavirus: Pharmacy | Department of Health and Social Care | Written Answers The country is well prepared to deal with any impacts of COVID-19 and we have stockpiles of generic drugs, including some over-the-counter m
Human Papillomavirus: Screening | Department of Health and Social Care | Written Answers Human papillomavirus (HPV) testing is the primary screening test used in the National Health Service Cervical Screening Programme.
Human Papillomavirus: Vaccination | Department of Health and Social Care | Written Answers Public Health England (PHE) is conducting surveillance activities to monitor the effectiveness of the National Human Papillomavirus (HPV) Va
Giant Cell Arteritis | Department of Health and Social Care | Written Answers The Department does not hold information about the number of people with Giant Cell Arteritis who lost their vision as a result of a late di
Giant Cell Arteritis | Department of Health and Social Care | Written Answers Giant Cell Arteritis (GCA) is one of over 6,000 rare diseases.
Cancer: Radiotherapy | Department of Health and Social Care | Written Answers A capacity planning exercise in England, run by NHS England and NHS Improvement, modelled radiotherapy activity levels over a five year peri
Radiotherapy: Medical Equipment | Department of Health and Social Care | Written Answers NHS England and NHS Improvement produced a stocktake, which included age, of linear accelerators in full clinical use in 2016 as part of the